Patient recruitment firm Trialbee joins forces with TriNetX

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Who_I_am)
(Image: Getty/Who_I_am)

Related tags: TriNetX, Trialbee, Patient recruitment

Trialbee and TriNetX are teaming up to accelerate research and develop new services with the goal of improving patient access to clinical trials as a care option.

A technology provider in the clinical trial patient matching and engagement space, Trialbee has announced a partnership with the global health network, TriNetX.

Trialbee CEO Lollo Eriksson described the partnership as a “great opportunity to leverage both organizations' capabilities to develop new services in order to optimize clinical trials to empower patients with clinical trials as a care option.”

“This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention,”​ Eriksson said in a statement.

According to the companies, the partnership also will involve work to develop new services aimed at accelerating clinical trials.

“Our collaboration with Trialbee further enhances our health care organizations’ capabilities to streamline patient identification and recruitment. We see this partnership as a complementary effort to our digital developments around protocol design, site identification, and access to patients,”​ said Maulik Mehta, senior vice president of corporate development at TriNetX.

Based in Cambridge, MA, TriNetX has partnered with health care organizations across 23 countries and thousands of sites, and recently was named as a technology partner in two coordinating centers of the US Food and Drug Administration’s (FDA) Sentinel System.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars